NCT07505173
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
Clinical trial condition
Carcinoma, Non-Small-Cell Lung
Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.
4,689 public trials
1,036 recruiting studies
Carcinoma, Non-Small-Cell Lung trial results
NCT07498933
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
Recruiting
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
NCT04762199
- Conditions
- Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT04933903
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Rhode Island Hospital Providence, Rhode Island, United States
Recruiting
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
NCT05681780
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT05837767
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
Recruiting
KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC
NCT05254184
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Recruiting
Phase 2 Study of Fingolimod in Lung Cancers
NCT06424067
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States
NCT06538038
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mercy Clinic Fort Smith Communities Fort Smith, Arkansas, United States
- Mercy Research Fort Smith, Arkansas, United States
- Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
NCT07444814
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
- Locations
-
- University of Arkansas Little Rock, Arkansas, United States
- UCLA - Hematology/Oncology Clinical Research Unit Los Angeles, California, United States
- St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States
- START - Midwest Grand Rapids, Michigan, United States